Genome Institute of Singapore-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Genome Institute of Singapore - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013392
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:30
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:シンガポール
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Genome Institute of Singapore (GIS) is a research institute that provides various research programs and services in different areas. The institute concentrates on genomic sciences to improve public health and prosperity in Singapore. It handles the latest in technology and comprises early career researchers such as next generation sequencing, high-throughput biology, genome engineering, genotyping, cytogenetics and single cell genomics, among others. GIS performs research in human genomics, cancer genomics, infectious diseases, genomics technologies, cancer stem cell biology, tissue regeneration and computational biology areas, among others. The institute offers its services to PhD, MD and M.B.B.S. graduates through its GIS Fellow Programs, to carry their research projects. GIS is headquartered in Singapore.

Genome Institute of Singapore – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Genome Institute of Singapore, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Genome Institute of Singapore, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Genome Institute of Singapore, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Genome Institute of Singapore, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Genome Institute of Singapore, Medical Devices Deals, 2011 to YTD 2017 9
Genome Institute of Singapore, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Genome Institute of Singapore, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Atreca Enters into Agreement with Genome Institute of Singapore 11
InvitroCue Enters into Research Agreement with Genome Institute of Singapore 12
PerkinElmer Forms Joint Venture with Genome Institute of Singapore 13
Genome Institute of Singapore Extends Research Agreement with Pacific Biosciences 14
Genome Institute of Singapore Enters Into Agreement With Oxford Biodynamics For Stem Cell Epigenetic Signatures 15
Genome Institue of Singapore Partners With Fluidigm To Establish Single-Cell Genomics Research Center 16
Appistry Enters Into Co-Development Agreement With Genome Institute of Singapore 17
Genome Institute of Singapore – Key Competitors 18
Genome Institute of Singapore – Key Employees 19
Genome Institute of Singapore – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Joint Venture 20
Recent Developments 21
Strategy And Business Planning 21
Jul 24, 2017: Launch of New Joint Innovation Laboratory to Advance Personalised Medicine for Cancer Treatment 21
Government and Public Interest 22
Jul 29, 2016: Singapore Scientists Grow Mini Human Brains 22
Jul 18, 2016: Singapore scientists discover new pathways leading to cancer progression 24
Jun 23, 2016: Scientists discover unsuspected bacterial link to bile duct cancer 26
Jun 03, 2016: Novel study on histones provides better understanding of gene regulation 27
Apr 11, 2016: Discovered Genes Reveal Novel Insights into Biology of Glaucoma 28
Product News 29
May 13, 2016: New technique paves the way for drug targeting to fight microbial resistance 29
Appendix 30
Methodology 30
About GlobalData 30
Contact Us 30
Disclaimer 30

List of Tables
Genome Institute of Singapore, Pharmaceuticals & Healthcare, Key Facts 2
Genome Institute of Singapore, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Genome Institute of Singapore, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Genome Institute of Singapore, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Genome Institute of Singapore, Deals By Therapy Area, 2011 to YTD 2017 8
Genome Institute of Singapore, Medical Devices Deals, 2011 to YTD 2017 9
Genome Institute of Singapore, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Atreca Enters into Agreement with Genome Institute of Singapore 11
InvitroCue Enters into Research Agreement with Genome Institute of Singapore 12
PerkinElmer Forms Joint Venture with Genome Institute of Singapore 13
Genome Institute of Singapore Extends Research Agreement with Pacific Biosciences 14
Genome Institute of Singapore Enters Into Agreement With Oxford Biodynamics For Stem Cell Epigenetic Signatures 15
Genome Institue of Singapore Partners With Fluidigm To Establish Single-Cell Genomics Research Center 16
Appistry Enters Into Co-Development Agreement With Genome Institute of Singapore 17
Genome Institute of Singapore, Key Competitors 18
Genome Institute of Singapore, Key Employees 19
Genome Institute of Singapore, Joint Venture 20

★海外企業調査レポート[Genome Institute of Singapore-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Star Gas Partners L.P.:企業の戦略・SWOT・財務情報
    Star Gas Partners L.P. - Strategy, SWOT and Corporate Finance Report Summary Star Gas Partners L.P. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • China Construction Bank Corp:企業の戦略・SWOT・財務分析
    China Construction Bank Corp - Strategy, SWOT and Corporate Finance Report Summary China Construction Bank Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Repligen Corp (RGEN):企業の財務・戦略的SWOT分析
    Summary Repligen Corp (Repligen) is a bioprocessing life science company that develops and commercializes consumable products for manufacturing biological drugs. The company's products include Protein A affinity resins, Protein A ligands, ELISA kits, alternating tangential flow system, OPUS pre pack …
  • Banco Promerica de Costa Rica S.A.:企業の戦略的SWOT分析
    Banco Promerica de Costa Rica S.A. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • TECT Aerospace, Inc.:企業の戦略・SWOT・財務情報
    TECT Aerospace, Inc. - Strategy, SWOT and Corporate Finance Report Summary TECT Aerospace, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • The Nature’s Bounty Co.:戦略・SWOT・企業財務分析
    The Nature’s Bounty Co. - Strategy, SWOT and Corporate Finance Report Summary The Nature’s Bounty Co. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Ballard Power Systems Inc. (BLDP)-エネルギー分野:企業M&A・提携分析
    Summary Ballard Power Systems Inc. (Ballard Power) is a renewable energy company. It designs, develops, manufactures, sells, and services proton exchange membrane (PEM) fuel cell products for power product markets, portable power, and material handling and backup power. The company’s product lines i …
  • International Consolidated Airlines Group, S.A.:企業の戦略・SWOT・財務分析
    International Consolidated Airlines Group, S.A. - Strategy, SWOT and Corporate Finance Report Summary International Consolidated Airlines Group, S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, o …
  • AAR Corp:企業の戦略・SWOT・財務情報
    AAR Corp - Strategy, SWOT and Corporate Finance Report Summary AAR Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Bank of Cyprus Public Company Ltd:企業のM&A・事業提携・投資動向
    Bank of Cyprus Public Company Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Bank of Cyprus Public Company Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mer …
  • AstraZeneca Plc (AZN)-製薬・医療分野:企業M&A・提携分析
    Summary AstraZeneca plc (AstraZeneca) is a biopharmaceutical company that endeavors to discover, produce and commercialize a wide range of prescription drugs. It focuses on therapy areas such as respiratory; cardiovascular and metabolic disease (CVMD); and cancer, besides autoimmune, infection and n …
  • Edison SpA (EDNR):企業の財務・戦略的SWOT分析
    Edison SpA (EDNR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Ionian Hotel Enterprises S.A.:企業の戦略・SWOT・財務分析
    Ionian Hotel Enterprises S.A. - Strategy, SWOT and Corporate Finance Report Summary Ionian Hotel Enterprises S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Cohu Inc (COHU):企業の財務・戦略的SWOT分析
    Cohu Inc (COHU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • J D Wetherspoon plc:企業の戦略・SWOT・財務情報
    J D Wetherspoon plc - Strategy, SWOT and Corporate Finance Report Summary J D Wetherspoon plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Ad Scientiam:企業の製品パイプライン分析
    Summary Ad Scientiam is a medical technology company that offers digital biomarkers which collects physiological and behavioral data. It provides mobile application which monitors patients’ behaviors and sharers the data to healthcare professionals. Ad Scientiam serves individuals, healthcare profes …
  • Eolus Vind AB (EOLU B):企業の財務・戦略的SWOT分析
    Summary Eolus Vind AB (Eolus Vind) is a wind farm developer that offers construction, development, and operation of green field projects and wind power plants. The company provides services such as consultancy services, administration, financing, development, and management of wind farms. It also of …
  • Ngai Hing Hong Co Ltd (1047):企業の財務・戦略的SWOT分析
    Ngai Hing Hong Co Ltd (1047) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Nick Scali Ltd (NCK):企業の財務・戦略的SWOT分析
    Nick Scali Ltd (NCK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Scholastic Corporation:企業の戦略・SWOT・財務情報
    Scholastic Corporation - Strategy, SWOT and Corporate Finance Report Summary Scholastic Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆